Latest news with #UW
Yahoo
5 hours ago
- Business
- Yahoo
Green Bay's nearly 150-year-old infrastructure gets failing grade in water report
GREEN BAY, Wis. (WFRV) – Green Bay's water utility earned strong marks on a new statewide report card, but one failing grade is raising concerns. The Wisconsin Waterworks Excellence Project, created by UW–Madison Professor Manny Teodoro, uses state data to grade all regulated drinking water systems in Wisconsin on a school-style scale. Thompson Center on Lourdes preparing for new space & name in honor of local philanthropist The goal: make complex water systems more understandable to the public and policymakers. 'These systems are buried, so they stay figuratively buried,' Teodoro said. 'The idea behind the report card is to make them familiar and easy to relate to.' Water Quality – Health: A Finance: B Communications: A+ Infrastructure and Operations: F Teodoro says Green Bay's aging infrastructure—some pipes date back to the 1880s—was the main driver of the failing grade. 'Green Bay loses a lot of water,' he said. 'Our Midwestern winters are very tough on water infrastructure… the systems are old in many parts of the city.' Still, Teodoro called Green Bay Water a 'well-led, professionally operated utility,' adding the city is already taking steps in the right direction. Utility General Manager Brian Powell agreed the infrastructure needs attention, but said the report card doesn't capture the full picture. 'We have a system that's over 140 years old… and part of our plan is to replace one percent of our infrastructure a year,' Powell said. 'The grading doesn't necessarily capture what we are doing.' He noted those upgrades were in motion before the report card came out. Neenah Foundry fire still under investigation for cause, additional details provided on response efforts 'The report card affirms we need to keep going down that path,' Powell said. 'We're proud of our water quality, finances, and communications.' The failing grade is tied to infrastructure, not the safety of drinking water, which scored an A. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
a day ago
- General
- Yahoo
Case dismissed for WA teen accused of stabbing, killing mom's boyfriend
The Brief A 16-year-old Pierce County teen's homicide case, involving the stabbing death of his mother's boyfriend, has been dismissed. Authorities determined the stabbing was a justifiable homicide, leading to the closure of the case. Due to juvenile laws, detectives could not directly interview the teen and obtained his statement through his defense attorney. PIERCE COUNTY, Wash. - A 16-year-old boy accused of stabbing and killing his mother's boyfriend last month has had his case dismissed, with authorities determining the homicide was justifiable. What's new in the case The Pierce County Sheriff's Office announced Thursday that the case, stemming from an April 30 incident, is now closed. The teen was booked into Remann Hall Juvenile Detention Center following the stabbing. Due to Washington state juvenile laws enacted in 2021, detectives were unable to directly interview the teen to gather his account of events. Investigators instead sought his statement through his defense attorney. He was released from Remann Hall on May 13 to home monitoring while the investigation continued. "We are thankful this case can finally be closed, and this young man can move forward with love and support from his family and community," the Pierce County Sheriff's Office stated in a May 29 news release. The backstory Deputies responded to a reported stabbing at the Conventry Court Apartments in the Midland area early on April 30. Authorities said the 16-year-old stabbed his mother's boyfriend during a domestic dispute involving his mother. The 23-year-old man was transported to a hospital in critical condition and later died from his injuries. Initial reports from early May identified the teen as 15 years old, and prosecutors had indicated plans to charge him as an adult with second-degree murder. Court documents at the time stated the teen told investigators he did not intend for the death to occur and that he was scared. The Source Information in this story came from the Pierce County Sheriff's Office. Judge orders UW lab technician to be released from ICE detention in Tacoma, WA Seattle-area Catholic school says US Border Patrol detained students of color Major 5-day SR 18 shut down to start Thursday in Snoqualmie Climbers, skier rescued at Mt. Baker in 48-hour span Mandatory driver's education to expand under new Washington law To get the best local news, weather and sports in Seattle for free, sign up for the daily FOX Seattle Newsletter. Download the free FOX LOCAL app for mobile in the Apple App Store or Google Play Store for live Seattle news, top stories, weather updates and more local and national news.
USA Today
a day ago
- Sport
- USA Today
Wisconsin football reveals start times, TV information for 2025 nonconference schedule
Wisconsin football reveals start times, TV information for 2025 nonconference schedule Wisconsin football released start times and television information for the first three games of its 2025 season on Thursday. UW's first contest of the 2025 slate is scheduled for 8:00 p.m. CT on Thursday, Aug. 28, against the Miami (Ohio) RedHawks at Camp Randall Stadium. The game will be broadcast on the Big Ten Network. Wisconsin's second bout, a home matchup against Middle Tennessee, is set to commence at 3:00 p.m. CT on Saturday, Sept. 6, on Fox Sports 1. A week later, Luke Fickell's program will square off against the Alabama Crimson Tide at Bryant-Denny Stadium in Tuscaloosa, Alabama, at 11:00 a.m. CT. That nationally-televised game will be broadcast on ESPN/ABC. The opener vs. the RedHawks marks the sixth time in the last eight seasons that UW will start its season with a night game. The program did so in 2024, securing a 28-14 victory over the Western Michigan Broncos in Madison. Most notably, the third contest of the season is a rematch of the Badgers' 2024 defeat at the hands of the Crimson Tide at Camp Randall. Alabama quarterback Jalen Milroe captained his squad to a 42-10 blowout victory. Other marquee battles, including at Michigan on Oct. 4, vs. Ohio State on Oct. 18, at Oregon on Oct. 25 and at Indiana on Nov. 15, have yet to receive a start time or television designation. Wisconsin went 5-7 in 2024 in the second full season under Fickell. The team recorded wins over Western Michigan, South Dakota, Purdue, Rutgers and Northwestern. The disappointing output prompted UW's brass to relieve former offensive coordinator Phil Longo of his duties in November. The program then signed former Kansas OC Jeff Grimes following the season's end. With former Maryland quarterback Billy Edwards Jr. now poised to start at quarterback for Grimes and Fickell, Wisconsin will work towards rediscovering its traditional identity on offense. That journey begins against the RedHawks at 8:00 p.m. CT on Aug. 28 at Camp Randall. Contact/Follow @TheBadgersWire on X (formerly Twitter) and like our page on Facebook to follow ongoing coverage of Wisconsin Badgers news, notes and opinion
Business Wire
2 days ago
- Business
- Business Wire
Archeus Technologies and Wisconsin Alumni Research Foundation Partner to Advance Radiopharmaceutical Therapy ART-101 into Clinical Development for Prostate Cancer
MADISON, Wis.--(BUSINESS WIRE)-- Archeus Technologies, a company developing multiple differentiated radiopharmaceutical therapies, and the Wisconsin Alumni Research Foundation (WARF), the patenting and licensing arm of the University of Wisconsin–Madison (UW), today announced a strategic collaboration to advance ART-101 – a promising receptor-based targeting molecule – into clinical development. ART-101 was discovered and developed at the Advanced Radiotheranostics Lab at UW–Madison, led by Dr. Reinier Hernandez, assistant professor of medical physics at the University of Wisconsin School of Medicine and Public Health. Aided by robust support from WARF through the WARF Accelerator, ART-101 has demonstrated enhanced pharmacology in preclinical studies, including significantly higher tumor uptake and retention relative to FDA-approved prostate cancer treatment Pluvicto ® (177Lu-PSMA-617). It has also shown superior pharmacokinetics, dosimetry and normal tissue toxicity profiles. Through a collaboration agreement with WARF, Archeus Technologies will lead Phase 1 clinical development of this asset with trial initiation planned for 2025. ART-101 is a next-generation prostate-specific membrane antigen (PSMA)-targeting small molecule. It is being evaluated as a radiopharmaceutical agent with the potential to deliver alpha-emitting isotopes with greater tolerability compared with current standards of care. 'With strong preclinical data supporting the continued development of ART-101, Archeus is eager to lead the evaluation of this novel candidate through first-in-human studies,' said Evan Sengbusch, Ph.D., chief executive officer of Archeus Technologies. 'Leveraging our team's proven experience ushering new radiopharmaceutical agents from concept through clinical translation, paired with our close collaboration with UW as a world-class radiopharmaceutical research organization, Archeus is uniquely positioned to progress ART-101 into the next stage of development. This asset adds to our Phase 1-ready portfolio of differentiated radiopharmaceutical therapies with the potential to provide curative responses to cancers that are particularly challenging to treat.' 'WARF is committed to investing in cutting-edge technologies and therapeutic candidates, like ART-101, that have significant potential to advance the theranostics landscape as well as treatment options for patients in need,' said Jeanine Burmania, senior director of intellectual property and licensing at WARF. 'Encouraging preclinical data suggest that ART-101 could help increase lifespan and be more effective in treating prostate cancer than current therapies. We're pleased to partner with Archeus Technologies to continue the development of this innovative asset and look forward to better understanding its role to potentially improve outcomes for prostate cancer patients.' ART-101 is compatible with multiple therapeutic isotopes, including actinium-225, lutetium-177 and terbium-161. When paired with these isotopes, preclinical data show that ART-101 provides significant potential benefit that could lead to improved outcomes for prostate cancer patients. About Archeus Technologies Archeus Technologies is a company developing differentiated radiopharmaceutical therapies for some of the most difficult-to-treat cancers. Starting with its Phase 1-ready therapeutic candidate, ARC-706, the company has assembled a growing pipeline of novel radiopharmaceutical therapy agents and companion diagnostic assets with the potential to provide curative responses to patients with advanced disease. Archeus is led by an executive team with proven radiopharmaceutical expertise and a demonstrated record of advancing innovative agents from discovery through clinical development. In addition, Archeus has a long-standing strategic collaboration with the University of Wisconsin-Madison (UW), a global leader in radiopharmaceuticals and theranostics. To learn more, visit About WARF Celebrating a century of service in 1925, the Wisconsin Alumni Research Foundation (WARF) patents and licenses discoveries from UW-Madison research, manages an investment portfolio generated from licensing and investment proceeds, and provides annual grants to the University of Wisconsin-Madison and the Morgridge Institute for Research to support further scientific investigation and research. By driving collaborations among researchers, investors, industry and entrepreneurs, WARF commercializes innovations from campus through various initiatives. WARF Accelerator improves the commercialization potential of university intellectual property through industry engagement and investment in proof-of-concept milestones to validate market potential, demonstrate commercial value and de-risk technology. WARF Therapeutics partners with UW-Madison and Morgridge Institute researchers employing an industry-focused approach to improve the value propositions of drug candidates. WARF Ventures is an early-stage venture fund that invests in startups based on UW/WARF technologies. Learn more at
Yahoo
3 days ago
- Business
- Yahoo
Trump and Harvard draw headlines, but UW is also imperiled by DOGE cuts
A funny thing happened on the way to the Trump Administration's all-out assault on the independence and productivity of American higher education. A majority of the American people decided they don't like it. An Associated Press/National Opinion Research Center poll conducted in early May found that 56% of Americans disapprove of the Republican president's approach to higher education. Six in 10 adults favor maintaining federal funding for scientific and medical research at colleges and universities while only about 3 in 10 support withholding federal funding from institutions for noncompliance with the president's goals or removing their tax-exempt status. Even Republicans are strongly divided on cutting funding to campuses that do not bow to Trump's demands. While about half are in favor, about one-quarter are opposed and a similar share are neutral. Americans are increasingly uncomfortable with government censorship that attempts to command and control what is studied and taught on our nation's campuses. The president's 'big beautiful' reconciliation bill, which narrowly passed in the House of Representatives May 22, proposes a staggering $351 billion in cuts to education and workforce programs. Almost all of that comes at the expense of low-income students and student loan borrowers. The bill would exclude one in five current Pell Grant recipients at community colleges, not Harvard, thereby disproportionately impacting low-income students and forcing hundreds of thousands out of college altogether. Opinion: As Wisconsin takes to water this spring, share your view on wake-enhanced boats The AP interviewed a 68-year-old Trump supporter who did not go to college herself, but made sure her children and grandchildren did. She worries that funding cuts will make it harder for people who need tuition aid to get an education. She sees it as the government 'getting in the way' of an educated society. She's right. The poll demonstrated that support for maintaining federal funding for scientific and medical research is bipartisan, with 75% of Democrats and 57% of Republicans in favor. They're right, too. Just look at Wisconsin. We now have 400-plus start-up companies in the state related to UW research, supporting 232,000 jobs. To highlight just one area of UW-Madison's life-saving research driven by federal funds, our scientists are working on screening for Alzheimer's with blood tests, as well as prevention therapies that would remove the plaques that cause the disease. Federally sponsored research at the UW makes vital contributions to the health of our economy and our citizens. For this boon to Wisconsin to continue, we need to attract and retain brilliant researchers here. A different poll conducted in March of this year by the journal "Nature" found that 75.3% of American scientists have been considering leaving the United States because of the disruptions to their research caused and threatened by federal funding reductions. Yet more disturbing, for early career scientists, the figure rose to 79.4%. Making America great is hardly about reversing the flight of scientists and intellectuals to this country from Europe during and after World War II. Continue to decimate the budgets of federal agencies such as the National Institutes of Health and the National Science Foundation, and we will lose both our scientists and our competitive edge. This at a time when China has announced an 8.3% increase in its research and development technology funding. Before my stint as president of the University of Wisconsin System, I served four years as chancellor of UW-Extension and four years before that as extension provost. UW-Extension then had offices in all 72 counties, as well as Wisconsin Public Broadcasting studios and reporters, and Small Business Development Centers, across the state. I spent those eight years traveling around Wisconsin, asking farmers, small business owners, and local government officials what the UW could do to improve their quality of life. Many of our fellow citizens I talked with did not have a college degree. Nevertheless, when I scratched down a little ways I found the pride they felt in the University of Wisconsin and what it was doing for their farms, their communities, their children and grandchildren. It's on you now, my Wisconsin senators, to defend the higher education system they built over many generations from the damage short-sighted federal idealogues would do to it. We need you to listen to the shifting opinions of the American people, including your Wisconsin constituents, who the AP/NORC poll shows want you to do just that. Kevin P. Reilly is president emeritus of the University of Wisconsin system. He served as president of the system from 2004 to 2013. This article originally appeared on Milwaukee Journal Sentinel: UW system could be hit by Trump attack on higher education | Opinion
